GSK’s Blenrep gains approval in Japan for advanced multiple myeloma
The approval is based on the findings of the DREAMM-7 and DREAMM-8 trials, which assessed Blenrep with BVd and BPd in patients previously treated at least once
Regeneron to acquire 23andMe’s assets in $256m deal
BioMarin to acquire Inozyme to enhance its enzyme therapy portfolio
BMS secures EC approval for Opdivo regimen to treat NSCLC with PD-L1
Sun Pharma Announces FDA Approval of Next Generation BLU-U Blue Light Photodynamic Therapy Illuminator for Actinic Keratosis
AGC Biologics, Quell Therapeutics partner to advance Treg cell therapies
Analysis
View More
Risks
View MoreSocietal polarisation and its impact on the pharmaceutical industry
Societal polarisation presents significant challenges for the pharmaceutical industry, affecting regulatory landscapes, public trust, innovation, and market dynamics
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry